Functional Predictors Discriminating Asthma-COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD). 2022

Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
Centre of Pulmonary Medicine, Hirslanden Private Hospital Group, Salem-Hospital, Bern, Switzerland.

A significant proportion of patients with obstructive lung disease have clinical and functional features of both asthma and chronic obstructive pulmonary disease (COPD), referred to as the asthma-COPD overlap (ACO). The distinction of these phenotypes, however, is not yet well-established due to the lack of defining clinical and/or functional criteria. The aim of our investigations was to assess the discriminating power of various lung function parameters on the assessment of ACO. From databases of 4 pulmonary centers, a total of 540 patients (231 males, 309 females), including 372 patients with asthma, 77 patients with ACO and 91 patients with COPD, were retrospectively collected, and gradients among combinations of explanatory variables of spirometric (FEV1, FEV1/FVC, FEF25-75), plethysmographic (sReff, sGeff, the aerodynamic work of breathing at rest; sWOB), static lung volumes, including trapped gases and measurements of the carbon monoxide transfer (DLCO, KCO) were explored using multiple factor analysis (MFA). The discriminating power of lung function parameters with respect to ACO was assessed using linear discriminant analysis (LDA). LDA revealed that parameters of airway dynamics (sWOB, sReff, sGeff) combined with parameters of static lung volumes such as functional residual capacity (FRCpleth) and trapped gas at FRC (VTG FRC) are valuable and potentially important tools discriminating between asthma, ACO and COPD. Moreover, sWOB significantly contributes to the diagnosis of obstructive airway diseases, independent from the state of pulmonary hyperinflation, whilst the diffusion capacity for carbon monoxide (DLCO) significantly differentiates between the 3 diagnostic classes. The complexity of COPD with its components of interaction and their heterogeneity, especially in discrimination from ACO, may well be differentiated if patients are explored by a whole set of target parameters evaluating, interactionally, flow limitation, airway dynamics, pulmonary hyperinflation, small airways dysfunction and gas exchange disturbances assessing specific functional deficits.

UI MeSH Term Description Entries
D008297 Male Males
D002248 Carbon Monoxide Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) Monoxide, Carbon
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D029424 Pulmonary Disease, Chronic Obstructive A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA. Airflow Obstruction, Chronic,COAD,COPD,Chronic Airflow Obstruction,Chronic Obstructive Airway Disease,Chronic Obstructive Lung Disease,Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Diseases,Airflow Obstructions, Chronic,Chronic Airflow Obstructions

Related Publications

Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
April 2018, Allergology international : official journal of the Japanese Society of Allergology,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
June 2020, COPD,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
January 2018, COPD,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
August 2023, Lung,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
January 2013, Journal of the American Board of Family Medicine : JABFM,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
December 2017, BMJ open,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
April 2018, Allergology international : official journal of the Japanese Society of Allergology,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
June 2017, Journal of thoracic disease,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
April 2023, The Journal of asthma : official journal of the Association for the Care of Asthma,
Richard Kraemer, and Fabian Gardin, and Hans-Jürgen Smith, and Florent Baty, and Jürg Barandun, and Andreas Piecyk, and Stefan Minder, and Jörg Salomon, and Martin Frey, and Martin H Brutsche, and Heinrich Matthys
November 2020, Immunology and allergy clinics of North America,
Copied contents to your clipboard!